Your browser doesn't support javascript.
loading
Clinical characterization of adult medulloblastoma and the effect of first-line therapies on outcome; The MD Anderson Cancer Center experience.
Majd, Nazanin K; Mastall, Maximilan; Lin, Heather; Dibaj, Seyede Shiva; Hess, Kenneth R; Yuan, Ying; Garcia, Manuela Martin-Bejarano; Fuller, Gregory N; Alfaro, Kristin D; Gule-Monroe, Maria K; Huse, Jason T; Khatua, Soumen; Rao, Ganesh; Sandberg, David I; Wefel, Jeffrey S; Yeboa, Debra N; Paulino, Arnold C; McGovern, Susan L; Zaky, Wafik; Mahajan, Anita; Suki, Dima; Weathers, Shiao-Pei; Harriso, Rebecca A; De Groo, John F; Puduvalli, Vinay K; Penas-Prado, Marta.
Afiliação
  • Majd NK; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Mastall M; Department of Neurology, Clinical Neuroscience Center and Brain Tumor Center, University Hospital Zurich, Zurich, Switzerland.
  • Lin H; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Dibaj SS; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Hess KR; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Yuan Y; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Garcia MM; Health Research Institute of the Hospital Clínico San Carlos, Madrid, Spain.
  • Fuller GN; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Alfaro KD; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Gule-Monroe MK; Department of Neuroradiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Huse JT; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Khatua S; Department of Pediatric Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Rao G; Department of Neurosurgery, Baylor College of Medicine, Houston, TX, USA.
  • Sandberg DI; Department of Pediatric Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Wefel JS; Department of Neuropsychology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Yeboa DN; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Paulino AC; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • McGovern SL; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Zaky W; Department of Pediatric Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Mahajan A; Department of Radiation-Oncology, Mayo Clinic, Rochester, Minnesota, USA.
  • Suki D; Department of Pediatric Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Weathers SP; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Harriso RA; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • De Groo JF; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Puduvalli VK; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Penas-Prado M; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.
Neurooncol Adv ; 3(1): vdab079, 2021.
Article em En | MEDLINE | ID: mdl-34377987
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Neurooncol Adv Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Neurooncol Adv Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos